Thomas Hager
-
- Occupational and environmental lung diseases 16
- Lung Cancer Diagnosis and Treatment 11
- Lung Cancer Treatments and Mutations 8
- Pleural and Pulmonary Diseases 8
- Medical Imaging and Pathology Studies 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
- Oncology top 10%
- Peptidase Inhibition and Analysis 5
- Cancer Research top 10%
- Ophthalmology top 5%
-
- Cancer Research and Treatments 7
- Co-authors
- Jeremias WohlschlaegerKurt Werner SchmidFabian MairingerDaniel C. ChristophRobert WalterDirk TheegartenClemens AignerSaskia Ting
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (4 papers)Clinical Lung Cancer (4 papers)Human Pathology (3 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Thomas Hager
67 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Pulmonary and Respiratory Medicine 529
- Oncology 371
- Cancer Research 169
- Ophthalmology 73
- Molecular Biology 339
Countries citing papers authored by Thomas Hager
This map shows the geographic impact of Thomas Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hager more than expected).
Fields of papers citing papers by Thomas Hager
This network shows the impact of papers produced by Thomas Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hager. The network helps show where Thomas Hager may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Hager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 37 | |
| 9 | 2020 | 17 | |
| 10 | 2019 | 7 | |
| 11 | 2019 | 13 | |
| 12 | 2019 | 25 | |
| 13 | 2017 | 19 | |
| 14 | 2017 | 20 | |
| 15 | 2016 | 31 | |
| 16 | 2013 | 1 | |
| 17 | 2013 | 37 | |
| 18 | 2013 | 9 | |
| 19 | 2012 | 7 | |
| 20 | Consideration of MIMO in the planning of LTE networks in urban and indoor scenarios | 2011 | 6 |
About Thomas Hager
Thomas Hager is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Oncology, having authored 70 papers that have together received 1.2k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (16 papers), Lung Cancer Diagnosis and Treatment (11 papers), Lung Cancer Treatments and Mutations (8 papers), Pleural and Pulmonary Diseases (8 papers), Medical Imaging and Pathology Studies (7 papers), Cancer Research and Treatments (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (529 citations), Oncology (371 citations) and Cancer Research (169 citations). Thomas Hager has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Jeremias Wohlschlaeger, Kurt Werner Schmid, Fabian Mairinger, Daniel C. Christoph, Robert Walter, Dirk Theegarten, Clemens Aigner, Saskia Ting, Thomas Mairinger and Claudia Vollbrecht. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Clinical Lung Cancer, Human Pathology, Scientific Reports and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.